[1]Yamada Y, Koshizuka K, Hanazawa T, et al.Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma[J].Int J Oncol, 2018, 52(1):166-178[2]Jou A, Hess J.Epidemiology and Molecular Biology of Head and Neck Cancer[J].Oncol Res Treat, 2017, 40(6):328-332[3]Poenitzsch Strong AM, Berry SM, Beebe DJ, et al.miFAST: A novel and rapid microRNA target capture method[J].Mol Carcinog, 2018, 57(4):559-566[4]Jafri MA, Al-Qahtani MH, Shay JW.Role of miRNAs in human cancer metastasis: Implications for therapeutic intervention[J].Semin Cancer Biol, 2017, 44:117-131[5]杜莉, 曹伟靖, 田莹,等.miR-140-5p对口腔鳞状细胞癌细胞增殖及凋亡的影响[J].口腔生物医学, 2017, 8(4):186-190[6]Nohata N, Hanazawa T, Kinoshita T, et al.Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma[J].Br J Cancer, 2013, 108(8):1648-1658[7]Kinoshita T, Nohata N, Hanazawa T, et al.Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma[J].Br J Cancer, 2013, 109(10):2636-2645[8]Su Z, Chen D, Zhang E, et al.MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma[J].Mol Med Rep, 2015, 12(1):1535-1543[9]Du P, Luan X, Liao Y, et al.MicroRNA-509-3p inhibits cell proliferation and invasion via downregulation of X-linked inhibitor of apoptosis in glioma[J].Oncol Lett, 2018, 15(1):1307-1312[10]Sun J, Li J, Zhang W, et al.MicroRNA-509-3p Inhibits Cancer Cell Proliferation and Migration via Upregulation of XIAP in Gastric Cancer Cells[J].Oncol Res, 2017, 25(3):455-461[11]Zhang L, Sun ZJ, Bian Y, et al.MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma[J].Cancer Lett, 2013, 331(2):230-238[12]Koshizuka K, Hanazawa T, Kikkawa N, et al.Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer[J].Cancer Sci, 2017, 108(8):1681-1692[13]Amato F, Tomaiuolo R, Nici F, et al.Exploitation of a very small peptide nucleic acid as a new inhibitor of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression[J].Biomed Res Int, 2014, 2014:610718-[14]Pandey R, Yang Y, Jackson L, et al.MicroRNAs regulating meis1 expression and inducing cardiomyocyte proliferation[J].Cardiovasc Regen Med, 2016, 3:e1468-[15]Citri A, Yarden Y.EGF-ERBB signalling: towards the systems level[J].Nat Rev Mol Cell Biol, 2006, 7(7):505-516[16]Zheng Y, Wang Z, Ding X, et al.Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma[J].Cell Prolif, 2017, 51(3):e12424-[17]Thelemann A, Petti F, Griffin G, et al.Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells[J].Mol Cell Proteomics, 2005, 4(4):356-376[18]Freudlsperger C, Burnett JR, Friedman JA, et al.EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy[J].Expert Opin Ther Targets, 2011, 15(1):63-74[19]Clark C, Shah S, Herman-Ferdinandez L, et al.Teasing out the best molecular marker in the AKT/mTOR pathway in head and neck squamous cell cancer patients[J].Laryngoscope, 2010, 120(6):1159-1165 |